RT Journal Article
T1 Recent advances in mesoporous silica nanoparticles for antitumor therapy: our contribution
A1 Baeza García, Alejandro
A1 Manzano García, Miguel
A1 Colilla Nieto, Montserrat
A1 Vallet Regí, María Dulce Nombre
AB Since 2001, when our research group proposed for the first time MCM-41 as a drug release system, the scientific community has demonstrated a growing interest in mesoporous silica nanoparticles (MSNs) for their revolutionary potential in nanomedicine. Among the diverse pathologies that can be treated with MSNs, cancer has received increasing attention. MSNs can be loaded with large amounts of therapeutic cargoes and once intravenously administrated preferentially accumulate in solid tumours via the enhanced permeation and retention (EPR) effect. Herein we report the recent developments achieved by our research group as a pioneer in this field, highlighting: the design of sophisticated MSNs as stimuli-responsive drug delivery systems to release the entrapped cargo upon exposure to a given stimulus while preventing the premature release of highly cytotoxic drugs before reaching the target; transporting non-toxic prodrugs and the enzyme responsible for its conversion into cytotoxic agents into the same MSNs; improving the selectivity and cellular uptake by cancer cells by active targeting of MSNs; increasing the penetration of MSNs within the tumour mass, which is one of the major challenges in the use of NPs to treat solid tumours.
PB Royal Society of Chemistry
SN 2047-4830
YR 2016
FD 2016-02-23
LK https://hdl.handle.net/20.500.14352/23074
UL https://hdl.handle.net/20.500.14352/23074
LA spa
NO 1 S. Parveen, R. Misra and S. K. Sahoo, Nanomed.: Nanotechnol.,Biol. Med., 2012, 8, 147–166.2 O. C. Farokhzad and R. Langer, ACS Nano, 2009, 3, 16–20.3 B. Y. S. Kim, J. T. Rutka and W. C. W. Chan,N. Engl. J. Med., 2010, 363, 2434–2443.4 S. Mura, J. Nicolas and P. Couvreur, Nat. Mater., 2013, 12,991–1003.5 R. Misra, S. Acharya and S. K. Sahoo, Drug Discovery Today,2010, 15, 842–850.6 F. Danhier, O. Feron and V. Préat, J. Controlled Release,2010, 148, 135–146.7 Y. Matsumura and H. Maeda, Cancer Res., 1986, 46, 6387–6392.8 R. K. Jain and T. Stylianopoulos, Nat. Rev. Clin. Oncol.,2010, 7, 653–664.9 M. Colilla, B. Gonzalez and M. Vallet-Regi, Biomater. Sci.,2013, 1, 114–134.10 J. H. Adair, M. P. Parette, E. İ. Altınoğlu and M. Kester, ACSNano, 2010, 4, 4967–4970.11 A. Baeza and M. Vallet-Regí, in Bio- and Bioinspired Nanomaterials,Wiley-VCH Verlag GmbH & Co. KGaA, 2014, pp.23–48, DOI: 10.1002/9783527675821.ch02.12 W. H. De Jong and P. J. A. Borm, Int. J. Nanomed., 2008, 3,133–149.13 M. Vallet-Regi, A. Ramila, R. P. del Real and J. Perez-Pariente,Chem. Mater., 2001, 13, 308–311.14 M. Vallet-Regí, F. Balas and D. Arcos, Angew. Chem., Int.Ed., 2007, 46, 7548–7558.15 A. Baeza, M. Colilla and M. Vallet-Regí, Expert Opin. DrugDelivery, 2014, 12, 319–337.16 P. Yang, S. Gai and J. Lin, Chem. Soc. Rev., 2012, 41, 3679–3698.17 F. Tang, L. Li and D. Chen, Adv. Mater., 2012, 24, 1504–1534.18 Z. Li, J. C. Barnes, A. Bosoy, J. F. Stoddart and J. I. Zink,Chem. Soc. Rev., 2012, 41, 2590–2605.19 M. Colilla, A. Baeza and M. Vallet-Regí, in The Sol–GelHandbook, ed. D. Levy and M. Zayat, Wiley-VCH VerlagGmbH & Co. KGaA, Weinheim, Germany, 2015, vol. 3, ch.42, pp. 1309–1344.20 M. Colilla and M. Vallet-Regi, in Smart Materials for DrugDelivery: Volume 2, ed. C. Alvarez-Lorenzo and A. Concheiro,The Royal Society of Chemistry, Cambridge, UnitedKingdom, 2013, vol. 2, ch. 15, pp. 63–89.21 M. Colilla and M. Vallet-Regi, in Chemoresponsive Materials:Stimulation by Chemical and Biological Signals, ed.H. J. Schneider, The Royal Society of Chemistry, Cambridge,United Kingdom, 2015, ch. 6, pp. 136–166, DOI:10.1039/9781782622420-00136.22 M. Vallet-Regi, M. Colilla and B. Gonzalez, Chem. Soc. Rev.,2011, 40, 596–607.23 M. Vallet-Regí, M. Manzano and M. Colilla, BiomedicalApplications of Mesoporous Ceramics: Drug Delivery, SmartMaterials and Bone Tissue Engineering, CRC Press, Taylor &Francis Group, Boca Raton, US, 2012.24 F. Hoffmann, M. Cornelius, J. Morell and M. Froeba,Angew. Chem., Int. Ed., 2006, 45, 3216–3251.25 C. Argyo, V. Weiss, C. Bräuchle and T. Bein, Chem. Mater.,2014, 26, 435–451.26 S. Giret, M. Wong Chi Man and C. Carcel, Chem. – Eur. J.,2015, 21, 13850–13865.27 S. K. Natarajan and S. Selvaraj, RSC Adv., 2014, 4, 14328–14334.28 S.-H. Wu, C.-Y. Mou and H.-P. Lin, Chem. Soc. Rev., 2013,42, 3862–3875.29 M. Vallet-Regi and E. Ruiz-Hernandez, Adv. Mater., 2011,23, 5177–5218.30 V. Mamaeva, C. Sahlgren and M. Lindén, Adv. Drug DeliveryRev., 2013, 65, 689–702.31 I. Slowing, B. G. Trewyn and V. S. Y. Lin, J. Am. Chem. Soc.,2006, 128, 14792–14793.32 F. Lu, S.-H. Wu, Y. Hung and C.-Y. Mou, Small, 2009, 5,1408–1413.33 B. G. Trewyn, J. A. Nieweg, Y. Zhao and V. S. Y. Lin, Chem.Eng. J., 2008, 137, 23–29.34 Y. Chen, H. Chen and J. Shi, Adv. Mater., 2013, 25, 3144–3176.35 S. P. Hudson, R. F. Padera, R. Langer and D. S. Kohane, Biomaterials,2008, 29, 4045–4055.36 Z. Tao, M. P. Morrow, T. Asefa, K. K. Sharma, C. Duncan,A. Anan, H. S. Penefsky, J. Goodisman and A.-K. Souid,Nano Lett., 2008, 8, 1517–1526.37 D.-M. Huang, T.-H. Chung, Y. Hung, F. Lu, S.-H. Wu,C.-Y. Mou, M. Yao and Y.-C. Chen, Toxicol. Appl. Pharmacol.,2008, 231, 208–215.38 J. Lu, M. Liong, Z. Li, J. I. Zink and F. Tamanoi, Small,2010, 6, 1794–1805.39 Y. Zhao, X. Sun, G. Zhang, B. G. Trewyn, I. I. Slowing andV. S. Y. Lin, ACS Nano, 2011, 5, 1366–1375.40 M. Joglekar, R. A. Roggers, Y. Zhao and B. G. Trewyn, RSCAdv., 2013, 3, 2454–2461.41 K. S. Butler, P. N. Durfee, C. Theron, C. E. Ashley,E. C. Carnes and C. J. Brinker, Small, DOI: 10.1002/smll.201502119.42 Y. Yang and C. Yu, Nanomed.: Nanotechnol., Biol. Med.,DOI: 10.1016/j.nano.2015.10.018.43 S. Baek, R. K. Singh, D. Khanal, K. D. Patel, E.-J. Lee,K. W. Leong, W. Chrzanowski and H.-W. Kim, Nanoscale,2015, 7, 14191–14216.44 S. Alberti, G. J. A. A. Soler-Illia and O. Azzaroni, Chem.Commun., 2015, 51, 6050–6075.45 N. Ž. Knežević and J.-O. Durand, ChemPlusChem, 2015, 80,26–36.46 Y. Wang, Q. Zhao, N. Han, L. Bai, J. Li, J. Liu, E. Che,L. Hu, Q. Zhang, T. Jiang and S. Wang, Nanomed.: Nanotechnol.,Biol. Med., 2015, 11, 313–327.47 K.-N. Yang, C.-Q. Zhang, W. Wang, P. C. Wang, J.-P. Zhouand X.-J. Liang, Cancer Biol. Med., 2014, 11, 34–43.48 Q. He and J. Shi, Adv. Mater., 2014, 26, 391–411.49 Y.-S. Lin, K. R. Hurley and C. L. Haynes, J. Phys. Chem. Lett.,2012, 3, 364–374.50 J. M. Rosenholm, V. Mamaeva, C. Sahlgren and M. Lindén,Nanomedicine, 2011, 7, 111–120.51 D. Tarn, C. E. Ashley, M. Xue, E. C. Carnes, J. I. Zink andC. J. Brinker, Acc. Chem. Res., 2013, 46, 792–801.52 Y. Zhao, J. L. Vivero-Escoto, I. I. Slowing, B. G. Trewyn andV. S. Y. Lin, Expert Opin. Drug Delivery, 2010, 7, 1013–1029.53 K. K. Coti, M. E. Belowich, M. Liong, M. W. Ambrogio,Y. A. Lau, H. A. Khatib, J. I. Zink, N. M. Khashab andJ. F. Stoddart, Nanoscale, 2009, 1, 16–39.54 A. Baeza, D. Arcos and M. Vallet-Regí, J. Phys.: Condens.Matter, 2013, 25, 484003.55 C. Boissiere, D. Grosso, A. Chaumonnot, L. Nicole andC. Sanchez, Adv. Mater., 2011, 23, 599–623.56 D. Arcos, V. Fal-Miyar, E. Ruiz-Hernandez, M. Garcia-Hernandez, M. L. Ruiz-Gonzalez, J. Gonzalez-Calbet andM. Vallet-Regi, J. Mater. Chem., 2012, 22, 64–72.Review Biomaterials Science812 | Biomater. Sci., 2016, 4, 803–813 This journal is © The Royal Society of Chemistry 201657 E. Ruiz-Hernández, A. Baeza and M. Vallet-Regí, ACS Nano,2011, 5, 1259–1266.58 R. Jin, G. Wu, Z. Li, C. A. Mirkin and G. C. Schatz, J. Am.Chem. Soc., 2003, 125, 1643–1654.59 R. Cheng, F. Meng, C. Deng, H.-A. Klok and Z. Zhong, Biomaterials,2013, 34, 3647–3657.60 Y.-Z. You, K. K. Kalebaila, S. L. Brock and D. Oupický,Chem. Mater., 2008, 20, 3354–3359.61 S. Chen, H. Zhong, B. Gu, Y. Wang, X. Li, Z. Cheng,L. Zhang and C. Yao, Mater. Sci. Eng., C, 2012, 32, 2199–2204.62 S. Furyk, Y. Zhang, D. Ortiz-Acosta, P. S. Cremer andD. E. Bergbreiter, J. Polym. Sci., Part A: Polym. Chem., 2006,44, 1492–1501.63 E. Guisasola, A. Baeza, M. Talelli, D. Arcos, M. Moros,J. M. de la Fuente and M. Vallet-Regí, Langmuir, 2015, 31,12777–12782.64 N. K. Mal, M. Fujiwara and Y. Tanaka, Nature, 2003, 421,350–353.65 D. P. Ferris, Y.-L. Zhao, N. M. Khashab, H. A. Khatib,J. F. Stoddart and J. I. Zink, J. Am. Chem. Soc., 2009, 131,1686–1688.66 J. Yue, S. Liu, R. Wang, X. Hu, Z. Xie, Y. Huang and X. Jing,Mol. Pharmaceutics, 2012, 9, 1919–1931.67 S. R. Sirsi and M. A. Borden, Adv. Drug Delivery Rev., 2014,72, 3–14.68 J. Wang, M. Pelletier, H. J. Zhang, H. S. Xia and Y. Zhao,Langmuir, 2009, 25, 13201–13205.69 J. Xuan, O. Boissière, Y. Zhao, B. Yan, L. Tremblay,S. Lacelle, H. Xia and Y. Zhao, Langmuir, 2012, 28, 16463–16468.70 J. L. Paris, M. V. Cabañas, M. Manzano and M. Vallet-Regí,ACS Nano, 2015, 9, 11023–11033.71 V. J. Venditto and F. C. Szoka, Adv. Drug Delivery Rev., 2013,65, 80–88.72 L. Bildstein, C. Dubernet and P. Couvreur, Adv. Drug DeliveryRev., 2011, 63, 3–23.73 J. Rautio, H. Kumpulainen, T. Heimbach, R. Oliyai, D. Oh,T. Jarvinen and J. Savolainen, Nat. Rev. Drug Discovery,2008, 7, 255–270.74 A. Baeza, E. Guisasola, A. Torres-Pardo, J. M. González-Calbet, G. J. Melen, M. Ramirez and M. Vallet-Regí, Adv.Funct. Mater., 2014, 24, 4625–4633.75 M. P. de Melo, T. M. de Lima, T. C. Pithon-Curi andR. Curi, Toxicol. Lett., 2004, 148, 103–111.76 H. Maeda, H. Nakamura and J. Fang, Adv. Drug DeliveryRev., 2013, 65, 71–79.77 H. Nakamura, F. Jun and H. Maeda, Expert Opin. DrugDelivery, 2015, 12, 53–64.78 M. Egeblad, E. S. Nakasone and Z. Werb, Dev. Cell, 2010,18, 884–901.79 E. Ruoslahti, S. N. Bhatia and M. J. Sailor, J. Cell Biol.,2010, 188, 759–768.80 J. M. Maris, N. Engl. J. Med., 2010, 362, 2202–2211.81 K. K. Matthay, R. E. George and A. L. Yu, Clin. Cancer Res.,2012, 18, 2740–2753.82 S. Ekelund, P. Nygren and R. Larsson, Biochem. Pharmacol.,2001, 61, 1183–1193.83 G. Villaverde, A. Baeza, G. J. Melen, A. Alfranca, M. Ramirezand M. Vallet-Regi, J. Mater. Chem. B, 2015, 3, 4831–4842.84 M. Lundqvist, J. Stigler, T. Cedervall, T. Berggård,M. B. Flanagan, I. Lynch, G. Elia and K. Dawson, ACS Nano,2011, 5, 7503–7509.85 N. Bertrand and J.-C. Leroux, J. Controlled Release, 2012,161, 152–163.86 A. T. Florence, J. Controlled Release, 2012, 164, 115–124.87 T. D. McKee, P. Grandi, W. Mok, G. Alexandrakis, N. Insin,J. P. Zimmer, M. G. Bawendi, Y. Boucher, X. O. Breakefieldand R. K. Jain, Cancer Res., 2006, 66, 2509–2513.88 A. Parodi, S. G. Haddix, N. Taghipour, S. Scaria,F. Taraballi, A. Cevenini, I. K. Yazdi, C. Corbo, R. Palomba,S. Z. Khaled, J. O. Martinez, B. S. Brown, L. Isenhart andE. Tasciotti, ACS Nano, 2014, 8, 9874–9883.89 M. R. Villegas, A. Baeza and M. Vallet-Regí, ACS Appl.Mater. Interfaces, 2015, 7, 24075–24081.90 E. S. Lee and Y. H. Bae, J. Controlled Release, 2008, 132,164–170.91 Y. L. Hu, Y. H. Fu, Y. Tabata and J. Q. Gao, J. ControlledRelease, 2010, 147, 154–162.92 Z. Gao, L. Zhang, J. Hu and Y. Sun, Nanomed.: Nanotechnol.,Biol. Med., 2013, 9, 174–184.93 I. Vegh, M. Grau, M. Gracia, J. Grande, P. de la Torre andA. I. Flores, Cancer Gene Ther., 2013, 20, 8–16.94 J. L. Paris, P. de la Torre, M. Manzano, M. V. Cabañas,A. I. Flores and M. Vallet-Regí, Acta Biomater., 2016, DOI:10.1016/j.actbio.2016.01.017.
NO RESEARCHER ID M-3378-2014 (María Vallet Regí)ORCID 0000-0002-6104-4889 (María Vallet Regí)RESEARCHER ID M-3316-2014 (Alejandro Baeza García)ORCID 0000-0002-8408-3389 (Alejandro Baeza García)	RESEARCHER ID K-3719-2014  (Miguel Manzano García)RESEARCHER ID M-3378-2014 (Miguel Manzano García)		ORCID 0000-0001-6238-6111 (Miguel Manzano García)
NO Ministerio de Economia y Competitividad (MINECO)
NO Agening Network of Excellence
DS Docta Complutense
RD 6 may 2024